Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 339

1.

Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies.

Yang H, Yang K, Khafagi A, Tang Y, Carey TE, Opipari AW, Lieberman R, Oeth PA, Lancaster W, Klinger HP, Kaseb AO, Metwally A, Khaled H, Kurnit DM.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7683-8.

2.

Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies.

Tachezy R, Mikysková I, Ludvíková V, Rob L, Kucera T, Slavík V, Beková A, Robová H, Pluta M, Hamsíková E.

Eur J Clin Microbiol Infect Dis. 2006 Aug;25(8):492-500.

PMID:
16896828
3.

Detection of human papillomavirus from archival tissues in cervical cancer patients in Mauritius.

Rughooputh S, Eddoo R, Manraj S, Jeebun N, Greenwell P.

J Clin Virol. 2006 Feb;35(2):173-8. Epub 2005 Aug 22.

PMID:
16115796
4.

Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer.

Ho CM, Chien TY, Huang SH, Lee BH, Chang SF.

Gynecol Oncol. 2006 Jul;102(1):54-60. Epub 2005 Dec 28.

PMID:
16386784
5.

Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.

Payan C, Ducancelle A, Aboubaker MH, Caer J, Tapia M, Chauvin A, Peyronnet D, Le Hen E, Arab Z, Legrand MC, Tran A, Postec E, Tourmen F, Avenel M, Malbois C, De Brux MA, Descamps P, Lunel F.

J Clin Microbiol. 2007 Mar;45(3):897-901. Epub 2007 Jan 17.

6.

[Detection and genotyping of high-risk human papillomavirus in cervical specimens].

Chacón J, Sanz I, Rubio MD, de la Morena ML, Díaz E, Mateos ML, Baquero F.

Enferm Infecc Microbiol Clin. 2007 May;25(5):311-6. Spanish.

PMID:
17504684
7.
8.

Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes.

Adams V, Schmid S, Zariwala M, Schmid M, Kleihues P, Briner J, Schäfer R.

Anticancer Res. 1999 Jan-Feb;19(1A):1-6.

PMID:
10226517
9.

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia.

Lie AK, Risberg B, Borge B, Sandstad B, Delabie J, Rimala R, Onsrud M, Thoresen S.

Gynecol Oncol. 2005 Jun;97(3):908-15. Epub 2005 Apr 15.

PMID:
15943992
10.
11.

Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.

Daponte A, Pournaras S, Mademtzis I, Hadjichristodoulou C, Kostopoulou E, Maniatis AN, Messinis IE.

J Clin Virol. 2006 Jul;36(3):189-93. Epub 2006 May 11.

PMID:
16690350
12.

Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen SM, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Int J Gynecol Pathol. 2006 Oct;25(4):383-92.

PMID:
16990717
13.

Presence of HPV in head and neck tumours: high prevalence in tonsillar localization.

Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M.

J Exp Clin Cancer Res. 2004 Dec;23(4):561-6.

PMID:
15743024
16.

HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level.

Berlin Grace VM, Niranjali Devaraj S, Radhakrishnan Pillai M, Devaraj H.

Gynecol Oncol. 2006 Oct;103(1):113-9. Epub 2006 Mar 22.

PMID:
16554086
17.

Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.

Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N.

J Clin Microbiol. 2008 Jan;46(1):274-80. Epub 2007 Oct 31.

18.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

PMID:
19141778
19.

Human papillomavirus in early laryngeal carcinoma.

Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, Schindler JS, Chung CH, Wirth PS, Meijer CJ, Snijders PJ, Yarbrough WG, Slebos RJ.

Laryngoscope. 2009 Aug;119(8):1531-7. doi: 10.1002/lary.20509.

PMID:
19489068
20.

Human papillomavirus in cervical and head-and-neck cancer.

Psyrri A, DiMaio D.

Nat Clin Pract Oncol. 2008 Jan;5(1):24-31. Review.

PMID:
18097454

Supplemental Content

Support Center